These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35946821)

  • 1. Major implications of single nucleotide polymorphisms in human carboxylesterase 1 on substrate bioavailability.
    Yerrakula G; Abraham S; John S; Zeharvi M; George SG; Senthil V; Maiz F; Rahman MH
    Biotechnol Genet Eng Rev; 2022 Aug; ():1-19. PubMed ID: 35946821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms.
    Wang X; Rida N; Shi J; Wu AH; Bleske BE; Zhu HJ
    Drug Metab Dispos; 2017 Nov; 45(11):1149-1155. PubMed ID: 28838926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.
    Thomsen R; Rasmussen HB; Linnet K;
    Drug Metab Dispos; 2014 Jan; 42(1):126-33. PubMed ID: 24141856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender.
    Shi J; Wang X; Nguyen JH; Bleske BE; Liang Y; Liu L; Zhu HJ
    Biochem Pharmacol; 2016 Nov; 119():76-84. PubMed ID: 27614009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
    Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
    Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
    Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M
    Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
    Merali Z; Ross S; Paré G
    Drug Metabol Drug Interact; 2014; 29(3):143-51. PubMed ID: 24988246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review.
    Liu Y; Li J; Zhu HJ
    Expert Opin Drug Metab Toxicol; 2024 May; 20(5):377-397. PubMed ID: 38706437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
    Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M
    Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Pharmacokinetic Herb-Drug Interactions: Have we Overlooked the Importance of Human Carboxylesterases 1 and 2?
    Xu J; Qiu JC; Ji X; Guo HL; Wang X; Zhang B; Wang T; Chen F
    Curr Drug Metab; 2019; 20(2):130-137. PubMed ID: 29600756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.
    Xie S; Borazjani A; Hatfield MJ; Edwards CC; Potter PM; Ross MK
    Chem Res Toxicol; 2010 Dec; 23(12):1890-904. PubMed ID: 21049984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic study of CES1 gene and enalapril efficacy.
    Hussain M; Basheer S; Khalil A; Haider QUA; Saeed H; Faizan M
    J Appl Genet; 2024 Jan; ():. PubMed ID: 38261266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxylesterase Inhibitors: An Update.
    Zou LW; Jin Q; Wang DD; Qian QK; Hao DC; Ge GB; Yang L
    Curr Med Chem; 2018; 25(14):1627-1649. PubMed ID: 29210644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human carboxylesterases: a comprehensive review.
    Wang D; Zou L; Jin Q; Hou J; Ge G; Yang L
    Acta Pharm Sin B; 2018 Sep; 8(5):699-712. PubMed ID: 30245959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Structural Variants of the
    Ikonnikova A; Kazakov R; Rodina T; Dmitriev A; Melnikov E; Zasedatelev A; Nasedkina T
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.
    Her L; Zhu HJ
    Drug Metab Dispos; 2020 Mar; 48(3):230-244. PubMed ID: 31871135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
    Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
    Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opossum carboxylesterases: sequences, phylogeny and evidence for CES gene duplication events predating the marsupial-eutherian common ancestor.
    Holmes RS; Chan J; Cox LA; Murphy WJ; VandeBerg JL
    BMC Evol Biol; 2008 Feb; 8():54. PubMed ID: 18289373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril.
    Zhu HJ; Appel DI; Johnson JA; Chavin KD; Markowitz JS
    Biochem Pharmacol; 2009 Apr; 77(7):1266-72. PubMed ID: 19185566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Per- and polyfluoroalkyl substances exert strong inhibition towards human carboxylesterases.
    Liu YZ; Pan LH; Bai Y; Yang K; Dong PP; Fang ZZ
    Environ Pollut; 2020 Aug; 263(Pt A):114463. PubMed ID: 32283456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.